4Filed Aug 12, 8:00 PM ET

CRL CEVP Shannon Parisotto Exercises Options and Sells 3,714 Shares

$CRL · CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Research Summary

AI-generated summary of this SEC filing

Updated

CRL CEVP Shannon Parisotto Exercises Options and Sells 3,714 Shares

What Happened
Shannon M. Parisotto, CEVP, Discovery & Safety Assessment at Charles River Laboratories (CRL), exercised 3,714 option shares at $179.66 per share (cost $667,257) on 2026-08-11 and immediately sold those 3,714 shares in the open market at $279.66 per share for gross proceeds of $1,038,657. A related derivative instrument was disposed of at exercise (reported at $0.00).

Key Details

  • Transaction date: 2026-08-11; Form 4 filed 2026-08-13 (timely within the 2-business-day reporting window).
  • Exercise: 3,714 shares at $179.66 — total exercise cost $667,257.
  • Sale: 3,714 shares at $279.66 — gross proceeds $1,038,657.
  • Net proceeds before taxes/fees (sale minus exercise cost): $371,400.
  • Footnote: Transactions occurred pursuant to a Rule 10b5-1 trading plan adopted March 4, 2026.
  • Shares owned after the transaction: Not specified in the provided filing.

Context
This was a same-day exercise and sale (a cashless-style outcome): the options were exercised and the underlying shares were immediately sold in the open market. The trade was executed under a pre-established 10b5-1 plan, which typically sets the timing and terms in advance and is a commonly used mechanism for scheduled insider sales. The filing appears timely and does not by itself indicate the insider’s future view of company prospects.